Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Charles A. Herzog, M.D.
Chronic Disease Research Group, Hennepin County Medical Center, University of Minnesota
Principal Investigator - Wojciech Zareba, M.D., Ph.D
University of Rochester
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Corona, California, United States
- Facility name not stated
Downey, California, United States
- Facility name not stated
Escondido, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Sacramento, California, United States
- Facility name not stated
San Dimas, California, United States
- Facility name not stated
San Luis Obispo, California, United States
- Facility name not stated
Whittier, California, United States
- Facility name not stated
Stamford, Connecticut, United States
- Facility name not stated
Hialeah, Florida, United States
- Facility name not stated
Miami, Florida, United States
- Facility name not stated
Pembroke Pines, Florida, United States
- Facility name not stated
Winter Garden, Florida, United States
- Facility name not stated
Albany, Georgia, United States
- Facility name not stated
Columbus, Georgia, United States
- Facility name not stated
Fort Wayne, Indiana, United States
- Facility name not stated
Greenbelt, Maryland, United States
- Facility name not stated
Detroit, Michigan, United States
- Facility name not stated
Rochester Hills, Michigan, United States
- Facility name not stated
Minneapolis, Minnesota, United States
- Facility name not stated
Kansas City, Missouri, United States
- Facility name not stated
Las Vegas, Nevada, United States
- Facility name not stated
New Brunswick, New Jersey, United States
- Facility name not stated
The Bronx, New York, United States
- Facility name not stated
Durham, North Carolina, United States
- Facility name not stated
Canton, Ohio, United States
- Facility name not stated
Greenville, South Carolina, United States
- Facility name not stated
Chattanooga, Tennessee, United States
- Facility name not stated
Knoxville, Tennessee, United States
- Facility name not stated
Houston, Texas, United States
- Facility name not stated
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2015
- Primary completion
- 31 Dec 2017
- Completion
- 31 Dec 2017
- Last update posted
- 19 Jan 2021
- Registered enrollment
- 66
- Registry id
- NCT02481206
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.